Biocon Ltd on Monday, May 13, said it has signed a semi-exclusive distribution and supply agreement with Medix for the commercialisation of its vertically-integrated obesity-treatment drug product, Liraglutide (generic Saxenda) in Mexico. The drug is used in chronic weight management, the company said in a stock exchange filing. Under this agreement, Biocon will handle obtaining regulator...
Open FlipJapanese technology giant SoftBank Group swung to a quarterly profit on Monday, reporting a net profit of 328.9 billion yen ($2.11 billion) for the January-March period. The Vision Fund investment unit booked an investment loss of 57.5 billion yen, after three consecutive quarters of profit. The net profit at group level compared with a 32 billion yen loss in the same period a year earlier.
Open FlipPiramal Alternatives, the investment arm of the Piramal Group, has picked a 9.85% stake in Odisha-headquartered micro lender Annapurna Finance through secondary equity deals. The equity purchases are valued at Rs 300 crore while the Piramal subsidiary has also invested another Rs 300 crore in Annapurna through subscribing to tier-2 convertible bonds.
Open Flip